Bioshares, Australia’s premininet biotechnology analsyst newsletter recently asked Cogentum to comment on the recent fall from grace of a significant Australian listed biotech. You can find the introduction and a link to the article below

The news from Tyrian Diagnostics that it will close down most of its business and lay off all of its staff is another [...]

[Read more →]

I am not sure how aware you are of the increasing trend towards crowd sourced solutions. But if not, you probably should be.
The central tenet of the crowd sourced solution is that it provides you access to a wider range of solutions at a lower cost.
Crowd sourcing is an emerging model right across a range of areas. Initially, it [...]

[Read more →]

Great news is continuing to emerge from the Australian biotech sctor.
We are glad to see that one of our clients, Acrux, is leading the charge as it continues to build a cogent story for its investors and the market.
Equally pleasing is the rapid progress of Universal Biosensors (sadly, not a client!). This company is, in our [...]

[Read more →]